Catalyst Wire Dossier Catalyst Wire Dossier

Ketorolac / Pitofenone / Fenpiverinium

· Darnitsa Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ketorolac / Pitofenone / Fenpiverinium, covering 2022-11-07 to 2022-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations [Phase 2, Phase 3]

See pricing